Issue 9, 2016

Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4

Abstract

Hepatitis C virus (HCV) is the major etiological agent of human non-A and non-B hepatitis affecting about 180 million people worldwide. The goal of the current study was to find effective anti-HCV proteins. As a result, defensins were selected as promising candidates due to their well-known anti-viral potential and small size. We conducted in vitro evaluation of two kinds of defensins (human α- and β-defensins and synthetic linear avian α-defensins) using tissue culture combined with reverse transcription nested PCR (RT-nested-PCR) and real-time PCR. Human α- and β-defensins showed strong anti-HCV activity in experiments on cellular protection, neutralization, and treatment at all concentrations used (10, 20 and 50 μg). The synthetic linear defensins could reach similar anti-HCV potential only at a noticeably higher concentration (250 μg) and do not show noticeable activity at 10 and 20 μg. This study suggests that defensins are potent anti-HCV agents.

Graphical abstract: Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4

Article information

Article type
Paper
Submitted
12 Apr. 2016
Accepted
30 Maijs 2016
First published
07 Jūn. 2016

Mol. BioSyst., 2016,12, 2785-2797

Author version available

Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4

E. H. Mattar, H. A. Almehdar, V. N. Uversky and E. M. Redwan, Mol. BioSyst., 2016, 12, 2785 DOI: 10.1039/C6MB00283H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements